These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
322 related items for PubMed ID: 19208098
1. Rituximab-based immunosuppression for autoimmune haemolytic anaemia in infants. Svahn J, Fioredda F, Calvillo M, Molinari AC, Micalizzi C, Banov L, Schmidt M, Caprino D, Marinelli D, Gallisai D, Dufour C. Br J Haematol; 2009 Apr; 145(1):96-100. PubMed ID: 19208098 [Abstract] [Full Text] [Related]
7. Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients. D'Arena G, Califano C, Annunziata M, Tartarone A, Capalbo S, Villani O, Amendola G, Pietrantuono G, Ferrara F, Pinto A, Musto P, D'Arco AM, Cascavilla N. Eur J Haematol; 2007 Jul; 79(1):53-8. PubMed ID: 17532766 [Abstract] [Full Text] [Related]
8. Consolidation treatment with rituximab induces complete and persistent remission of mixed type Evans syndrome. Rodella E, Pacquola E, Bianchini E, Ramazzina E, Paolini R. Blood Coagul Fibrinolysis; 2008 Jun; 19(4):315-8. PubMed ID: 18469554 [Abstract] [Full Text] [Related]
10. Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximab. Swords R, Nolan A, Fay M, Quinn J, O'Donnell R, Murphy PT. Clin Lab Haematol; 2006 Feb; 28(1):57-9. PubMed ID: 16430461 [Abstract] [Full Text] [Related]
11. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient. Gentile M, Lucia E, Iorio C, Vigna E, Mazzone C, Morelli R, Bisconte MG, Gentile C, Morabito F. Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461 [Abstract] [Full Text] [Related]
13. [Delayed response to rituximab of cold agglutinin haemolytic disease]. Calvo-Villas JM, Cuesta Tovar J, Carreter de Granda E, Sicilia Guillén F. An Med Interna; 2006 May; 23(5):224-8. PubMed ID: 16817700 [Abstract] [Full Text] [Related]
14. Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus. Perrotta S, Locatelli F, La Manna A, Cennamo L, De Stefano P, Nobili B. Br J Haematol; 2002 Feb; 116(2):465-7. PubMed ID: 11841453 [Abstract] [Full Text] [Related]
15. [Autoimmune haemolytic anaemia: a review and report of four cases]. Nyilas R, Székely B, Váróczy L, Simon Z, Árokszállási A, Illés Á, Gergely L. Orv Hetil; 2015 Mar; 156(11):449-56. PubMed ID: 25749539 [Abstract] [Full Text] [Related]
16. A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia. Birgens H, Frederiksen H, Hasselbalch HC, Rasmussen IH, Nielsen OJ, Kjeldsen L, Larsen H, Mourits-Andersen T, Plesner T, Rønnov-Jessen D, Vestergaard H, Klausen TW, Schöllkopf C. Br J Haematol; 2013 Nov; 163(3):393-9. PubMed ID: 23981017 [Abstract] [Full Text] [Related]
17. Anti-CD20 monoclonal antibody in acute life threatening haemolytic anaemia complicating childhood onset SLE. Abdwani R, Mani R. Lupus; 2009 Apr; 18(5):460-4. PubMed ID: 19318402 [Abstract] [Full Text] [Related]